Myrexis, Inc. (MYRX)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Jun 18, 2025
-96.97%
Market Cap 6.90K
Revenue (ttm) n/a
Net Income (ttm) -11.62M
Shares Out 34.48M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 150
Average Volume 62,944
Open 0.0002
Previous Close 0.0002
Day's Range 0.0002 - 0.0002
52-Week Range 0.0001 - 0.0080
Beta 0.93
RSI 9.72
Earnings Date n/a

About Myrexis

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
CEO Jonathan Couchman
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MYRX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.